{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:19:24Z","timestamp":1791839964942,"version":"4.3.4"},"reference-count":50,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Dermatol"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusions (CSIIs) are the current standard treatment devices for type 1 diabetes (T1D) management. With a high prevalence of T1D beginning in pediatrics and carrying into adulthood, insufficient glycemic control leads to poor patient outcomes. Dermatologic complications such as contact dermatitis, lipodystrophies, and inflammatory lesions are among those associated with CGM and CSII, which reduce glycemic control and patient compliance.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This systematic review aims to explore the current literature surrounding dermatologic complications of CGM and CSII as well as the impact on patient outcomes.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A systematic review of the literature was carried out using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines using 5 online databases. Included articles were those containing primary data relevant to human participants and adverse reactions to CGM and CSII devices in pediatric populations, of which greater than 50% of the sample size were aged 0\u201021 years. Qualitative analysis was chosen due to the heterogeneity of outcomes.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Following the application of exclusion criteria, 25 studies were analyzed and discussed. An additional 5 studies were identified after the initial search and inclusion. The most common complication covered is contact dermatitis, with 13 identified studies. Further, 7 studies concerned lipodystrophies, 5 covered nonspecific cutaneous changes, 3 covered unique cutaneous findings such as granulomatous reactions and panniculitis, and 2 discussed user acceptability.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The dermatologic complications of CGM and CSII pose a potential risk to long-term glycemic control in T1D, especially in young patients where skin lesions can lead to discontinuation. Increased manufacturer transparency is critical and further studies are needed to expand upon the current preventative measures such as device site rotation and steroid creams, which lack consistent effectiveness.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/59824","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T11:28:48Z","timestamp":1722857328000},"page":"e59824-e59824","source":"Crossref","is-referenced-by-count":14,"title":["Cutaneous Adverse Effects From Diabetes Devices in Pediatric Patients With Type 1 Diabetes Mellitus: Systematic Review"],"prefix":"10.2196","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5109-2405","authenticated-orcid":false,"given":"Alicia","family":"Podwojniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-1456","authenticated-orcid":false,"given":"Joseph","family":"Flemming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5756-6609","authenticated-orcid":false,"given":"Isabella J","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9296-9609","authenticated-orcid":false,"given":"Hira","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4497-2866","authenticated-orcid":false,"given":"Zachary","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8045-4357","authenticated-orcid":false,"given":"Anne","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"issue":"9911","key":"R1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","journal-title":"Lancet"},{"issue":"8","key":"R2","doi-asserted-by":"publisher","DOI":"10.3390\/life13081663","article-title":"Current technologies for managing type 1 diabetes mellitus and their impact on quality of life\u2014a narrative review","volume":"13","author":"Elian","journal-title":"Life (Basel)"},{"issue":"4","key":"R3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.21037\/tp.2017.10.04","article-title":"Psychosocial aspects of diabetes management: dilemma of diabetes distress","volume":"6","author":"Tareen","journal-title":"Transl Pediatr"},{"issue":"5","key":"R4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.amjms.2019.08.008","article-title":"Insulin pumps: review of technological advancement in diabetes management","volume":"358","author":"Sora","journal-title":"Am J Med Sci"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40257-018-0400-7","article-title":"Cutaneous adverse effects of diabetes mellitus medications and medical devices: a review","volume":"20","author":"Jedlowski","journal-title":"Am J Clin Dermatol"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","journal-title":"BMJ"},{"issue":"3","key":"R7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach","volume":"13","author":"Aromataris","journal-title":"Int J Evid Based Healthc"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/PRS.0b013e318219c171","article-title":"The levels of evidence and their role in evidence-based medicine","volume":"128","author":"Burns","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/1932296820918894","article-title":"Cutaneous reactions to continuous glucose monitoring and continuous subcutaneous insulin infusion devices in type 1 diabetes mellitus","volume":"15","author":"Rigo","journal-title":"J Diabetes Sci Technol"},{"issue":"9","key":"R10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1089\/dia.2019.0142","article-title":"Benefits and barriers of continuous glucose monitoring in young children with type 1 diabetes","volume":"21","author":"Hilliard","journal-title":"Diabetes Technol Ther"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110922","article-title":"High incidence of skin reactions secondary to the use of adhesives in glucose sensors or insulin pumps for the treatment of children with type 1 diabetes","volume":"204","author":"Gen\u00e8ve","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"R12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/dia.2018.0339","article-title":"Flash glucose monitoring accepted in daily life of children and adolescents with type 1 diabetes and reduction of severe hypoglycemia in real-life use","volume":"21","author":"Messaaoui","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"R13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1089\/dia.2023.0137","article-title":"Ultrasound detected subcutaneous changes in a pediatric cohort after initiation of a new insulin pump or glucose sensor","volume":"25","author":"S\u00f8rensen","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"R14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/cod.13664","article-title":"Contact dermatitis caused by glucose sensors, insulin pumps, and tapes: results from a 5\u2010year period","volume":"84","author":"Ahrensb\u00f8ll\u2010Friis","journal-title":"Cont Derm"},{"issue":"5","key":"R15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/cod.14166","article-title":"Contact dermatitis in children caused by diabetes devices","volume":"87","author":"Alves da Silva","journal-title":"Cont Derm"},{"issue":"6","key":"R16","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1177\/1932296820947072","article-title":"High frequency of dermatological complications in children and adolescents with type 1 diabetes: a web-based survey","volume":"15","author":"Lombardo","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"R17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/cod.13429","article-title":"Contact dermatitis caused by glucose sensors in diabetic children","volume":"82","author":"Herman","journal-title":"Cont Derm"},{"issue":"2","key":"R18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/cod.13815","article-title":"An unexpected source of glucose monitor\u2010associated allergic contact dermatitis","volume":"85","author":"Huang","journal-title":"Cont Derm"},{"issue":"4","key":"R19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/cod.14274","article-title":"Allergic contact dermatitis caused by a new insulin pump system containing isobornyl acrylate","volume":"88","author":"Enberg","journal-title":"Cont Derm"},{"issue":"4","key":"R20","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.234","article-title":"A toddler with systemic contact dermatitis caused by diabetes devices","volume":"3","author":"Lyngstadaas","journal-title":"Skin Health Dis"},{"issue":"5","key":"R21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/cod.14281","article-title":"Allergic contact dermatitis elicited by insulin infusion sets: first case reported in Poland","volume":"88","author":"Cicho\u0144","journal-title":"Cont Derm"},{"issue":"2","key":"R22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/bjd.20751","article-title":"Allergic contact dermatitis caused by dipropylene glycol diacrylate in the Omnipod\u00ae insulin pump","volume":"186","author":"Ulriksdotter","journal-title":"Br J Dermatol"},{"issue":"3","key":"R23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/jdv.16981","article-title":"Continuous glucose monitoring systems give contact dermatitis in children and adults despite efforts of providing less \u201callergy- prone\u201d devices: investigation and advice hampered by insufficient material for optimized patch test investigations","volume":"35","author":"Svedman","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.846137","article-title":"Technologies for type 1 diabetes and contact dermatitis: therapeutic tools and clinical outcomes in a cohort of pediatric patients","volume":"13","author":"Passanisi","journal-title":"Front Endocrinol"},{"issue":"1","key":"R25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/cod.13243","article-title":"N,N-dimethylacrylamide\u2014a new sensitizer in the FreeStyle Libre glucose sensor","volume":"81","author":"Mowitz","journal-title":"Cont Derm"},{"issue":"17-18","key":"R26","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1111\/jocn.16071","article-title":"Local complications of insulin administration sites and effect on diabetes management","volume":"31","author":"Demir","journal-title":"J Clin Nurs"},{"issue":"7","key":"R27","doi-asserted-by":"publisher","DOI":"10.3390\/children9071087","article-title":"The impact of insulin-induced lipodystrophy on glycemic variability in pediatric patients with type 1 diabetes","volume":"9","author":"Lombardo","journal-title":"Children (Basel)"},{"issue":"1","key":"R28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.15690\/vsp.v19i1.2082","article-title":"Dermatological complications of insulin therapy in children with type 1 diabetes: cross-sectional study","volume":"19","author":"Vitebskaya","journal-title":"Curr Pediatr"},{"issue":"8","key":"R29","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/pedi.13130","article-title":"Pediatric diabetes and skin disease (PeDiSkin): a cross-sectional study in 369 children, adolescents and young adults with type 1 diabetes","volume":"21","author":"Burgmann","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s13300-018-0561-7","article-title":"Impact of insulin injection and infusion routines on lipohypertrophy and glycemic control in children and adults with diabetes","volume":"10","author":"Deeb","journal-title":"Diabetes Ther"},{"issue":"2","key":"R31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s13340-021-00547-w","article-title":"Laser treatment for lipoatrophy in children with diabetes type 1","volume":"13","author":"Xatzipsalti","journal-title":"Diabetol Int"},{"issue":"7","key":"R32","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/pedi.13094","article-title":"Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine?","volume":"21","author":"Kordonouri","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/pde.14438","article-title":"A newly described cutaneous reaction at sites of insulin pump use in a child with type 1 diabetes","volume":"38","author":"Perez","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"R34","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1111\/pde.14430","article-title":"Painful nodules on the abdomen of a teenage male","volume":"38","author":"Smith","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"R35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jcjd.2022.08.006","article-title":"Insulin reactions: what do you do when your treatment\u2019s the trigger?","volume":"47","author":"Edwards","journal-title":"Can J Diabetes"},{"issue":"1","key":"R36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2337\/cd17-0053","article-title":"Adoption barriers for continuous glucose monitoring and their potential reduction with a fully implanted system: results from patient preference surveys","volume":"36","author":"Engler","journal-title":"Clin Diabetes"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1177\/1179551420910122","article-title":"Acceptability of the FreeStyle Libre flash glucose monitoring system: the experience of young patients with type 1 diabetes","volume":"13","author":"Al Hayek","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"5","key":"R38","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/jdi.13023","article-title":"Allergic contact dermatitis caused by isobornyl acrylate when using the FreeStyle Libre","volume":"10","author":"Mine","journal-title":"J Diabetes Investig"},{"issue":"1","key":"R39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/DER.0000000000000549","article-title":"Isobornyl acrylate","volume":"31","author":"Aerts","journal-title":"Dermatitis"},{"issue":"5","key":"R40","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/pde.14767","article-title":"Severe allergic contact dermatitis to two different continuous glucose monitoring devices in a patient with glycogen storage disease type 9b","volume":"38","author":"Teufel-Sch\u00e4fer","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"R41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/0394632017700431","article-title":"Long-acting insulin allergy in a diabetic child","volume":"30","author":"Mastrorilli","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"9","key":"R42","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.2337\/dc23-0426","article-title":"Evaluation of insulin pump infusion sites in type 1 diabetes: the DERMIS study","volume":"46","author":"Kalus","journal-title":"Diabetes Care"},{"issue":"8","key":"R43","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/dme.12194","article-title":"A practical, clinical approach to the assessment and management of suspected insulin allergy","volume":"30","author":"Jacquier","journal-title":"Diabet Med"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.3.155","article-title":"Immunogenicity and allergenic potential of animal and human insulins","volume":"16 Suppl 3","author":"Schernthaner","journal-title":"Diabetes Care"},{"issue":"3","key":"R45","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s13300-016-0187-6","article-title":"Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: are we sure everything is clear?","volume":"7","author":"Gentile","journal-title":"Diabetes Ther"},{"issue":"3","key":"R46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1365-2230.1989.tb00938.x","article-title":"Zinc-induced granuloma\u2014a unique complication of insulin therapy","volume":"14","author":"Jordaan","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"R47","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00592-019-01446-y","article-title":"\u201cOut of the box\u201d solution for skin problems due to glucose-monitoring technology in youth with type 1 diabetes: real-life experience with fluticasone spray","volume":"57","author":"Paret","journal-title":"Acta Diabetol"},{"issue":"4","key":"R48","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/1932296820911105","article-title":"Skin reaction report form: development and design of a standardized report form for skin reactions due to medical devices for diabetes management","volume":"15","author":"Freckmann","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"R49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/1932296819870849","article-title":"Cutaneous complications with continuous or flash glucose monitoring use: systematic review of trials and observational studies","volume":"14","author":"Asarani","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"R50","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s40519-019-00716-6","article-title":"Psychopathological and psychiatric evaluation of patients affected by lipodystrophy","volume":"25","author":"Calabr\u00f2","journal-title":"Eat Weight Disord"}],"container-title":["JMIR Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/derma.jmir.org\/2024\/1\/e59824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:32:16Z","timestamp":1785537136000},"score":1,"resource":{"primary":{"URL":"https:\/\/derma.jmir.org\/2024\/1\/e59824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":50,"URL":"https:\/\/doi.org\/10.2196\/59824","relation":{},"ISSN":["2562-0959"],"issn-type":[{"value":"2562-0959","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"article-number":"v7i9911e59824"}}